Phase II Trial of Bevacizumab (Avastin) Plus Pemetrexed (Alimta) and Carboplatin in Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)
I am 18 years of age or older. I have advanced non-small lung cancer. I have not had any
major surgical procedures within 28 days prior to my starting treatment.
I have high blood pressure that is controlled. I am not on heparin, coumadin or lovonox
for treatment of medical conditions. I do not have serious wound healing problems. I have
not received any previous treatment, except radiation therapy for my disease.
Type of Study:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
James Stevenson, M.D.
Cooper University Hospital
United States: Food and Drug Administration
- Untreated Advanced Non-Small Cell Lung Cancer
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
|The CINJ at Cooper University Hospital
||Voorhees, New Jersey 08043